Top Liver Cancer Abstracts to Watch at ASCO GI 2025

(6:30)

GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET

(20:48)

ASCO GI Studies to Monitor

(3:27)

What Changes Monday Morning? | Gastrointestinal Cancers ASCO 2021 Review

(1:31:47)

Why Pamrevlumab failed in Pancreatic Cancer? Unpacking Precision Promise Trial Results ASCO GI

(2:22)

ASCO Memphis 2024 | GI Cancer

(54)

ASCO GI: CD47 Blockade Combo Therapy Shows Antitumor Potential in Treated HER2+ Gastric Cancer

(3:27)

Officio Narrativus #102: Horus vs Emperador! Luz vs Oscuridad, el sol vs la luna, blancos vs ne

(2:16:5)

🚑⚽️ ARRIVA L'AMBULANZA! PAURA CONTRO la JUNIORES NAZIONALE del VARESE (SERIE D)

(31:39)

ctDNA and MRD | 2023 Best of GI Cancer Conference

(58:52)

Immunotherapy in CRC | 2023 Best of GI Cancer Conference

(35:42)

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. Stintzing

(9:55)

GI CONNECT Update from ASCO 2024

(8:19)

Bananirou hace speedrun de GTA SA y pierde por leer a Ayrton

(1:40:36)

SPOTLIGHT: zolbetuximab and m-FOLFOX6 in CLDN18.2+, HER2- GEJ cancer

(2:49)

GI ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Mark Lewis

(19:42)

研究所紹介【国立がん研究センター研究所】

(4:30)

Botensilimab and Balstilimab – ASCO GI 2025 and Beyond

(4:47)

2022 ASCO GI Cancers Symposium Keynote: Precision Medicine, AI and Innovation

(32:57)

ASCO GI 2023 highlights: AI in gastrointestinal cancers

(26)

ASCO GI 2023 highlights

(41)

Top 5 ASCO GI 2025 Abstracts

(1:39)

Updates from ASCO GI: 2023 West Oncology

(1:26)

ASCO 2023 Updates Webinar

(1:1:3)

Dr. John Marshall - GI Cancer Update | ASCO Direct™ Best of Oncology Conference 2024

(42:10)

Highlights in gastric and colorectal cancer at ASCO GI 2023

(1:28)

BRAF-altered CRC highlights from ASCO GI 2025

(4:29)